12/21
07:52 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at Raymond James to a "moderate buy" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at Raymond James to a "moderate buy" rating.
12/21
07:52 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at Raymond James to a "moderate buy" rating.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at Raymond James to a "moderate buy" rating.
12/9
09:19 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at Sidoti from a "buy" rating to a "neutral" rating. They now have a $90.00 price target on the stock.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at Sidoti from a "buy" rating to a "neutral" rating. They now have a $90.00 price target on the stock.
12/9
09:19 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at Sidoti from a "buy" rating to a "neutral" rating. They now have a $90.00 price target on the stock.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at Sidoti from a "buy" rating to a "neutral" rating. They now have a $90.00 price target on the stock.
12/9
08:49 am
pbh
Prestige Consumer downgraded to Neutral from Buy at Sidoti
Low
Report
Prestige Consumer downgraded to Neutral from Buy at Sidoti
12/9
08:49 am
pbh
Prestige Consumer downgraded to Neutral from Buy at Sidoti
Low
Report
Prestige Consumer downgraded to Neutral from Buy at Sidoti
11/11
11:42 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "buy" rating re-affirmed by analysts at DA Davidson. They now have a $95.00 price target on the stock.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "buy" rating re-affirmed by analysts at DA Davidson. They now have a $95.00 price target on the stock.
11/11
11:42 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "buy" rating re-affirmed by analysts at DA Davidson. They now have a $95.00 price target on the stock.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "buy" rating re-affirmed by analysts at DA Davidson. They now have a $95.00 price target on the stock.
11/11
11:33 am
pbh
Rating for PBH
Low
Report
Rating for PBH
11/11
11:33 am
pbh
Rating for PBH
Low
Report
Rating for PBH